Newron Pharmaceuticals S.p.A. Stock
Stocks
NWRN
IT0004147952
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
19:30:26 12/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 11.72 CHF | -0.34% |
|
-4.40% | -50.86% |
| 07-03 | Newron Pharmaceuticals to Make Changes to Phase 3 Trial of Schizophrenia Treatment | MT |
| 05-05 | Edison Is Not Overly Concerned About a Trial Suspension |  |
| Market Cap | 260M 300M 244M 222M 418M 28.65B 425M 2.87B 1.12B 14.35B 1.13B 1.1B 47.84B | P/E 2026 * |
-9.21x | P/E 2027 * | 33.8x |
|---|---|---|---|---|---|
| Enterprise Value | 299M 345M 280M 255M 480M 32.91B 488M 3.29B 1.29B 16.48B 1.3B 1.27B 54.95B | EV / Sales 2026 * |
27.6x | EV / Sales 2027 * | 6.13x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Newron Pharmaceuticals S.p.A.
| 1 day | -0.34% | ||
| 1 week | -4.40% | ||
| Current month | +0.51% | ||
| 1 month | -0.68% | ||
| 3 months | -17.11% | ||
| 6 months | -39.84% | ||
| Current year | -50.86% |
| 1 week | 11.64 |  | 12.64 |
| 1 month | 11.24 | | 13 |
| Current year | 11.24 | | 31.85 |
| 1 year | 6.91 | | 31.85 |
| 3 years | 4.09 | | 31.85 |
| 5 years | 1.01 | | 31.85 |
| 10 years | 0.9 | | 31.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stefan Weber
CEO | Chief Executive Officer | 62 | 15/05/2012 |
Roberto Galli
DFI | Director of Finance/CFO | - | 01/01/2012 |
Filippo Moriggia
COO | Chief Operating Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Stefan Weber
BRD | Director/Board Member | 62 | 15/05/2012 |
Gillian Dines
BRD | Director/Board Member | - | 01/04/2023 |
Margarita Chavez
BRD | Director/Board Member | - | 17/04/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/12/25 | Fiscal year | Founder | 5,465 | 0.0274% | ||
| 03/12/25 | Sell | 5,465 | 0.0274% | |||
| 27/11/25 | Fiscal year | Founder | 14,567 | 0.0730% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.34% | -4.40% | +48.17% | +95.33% | 302M | |
| -1.60% | +0.86% | +3.70% | +14.41% | 49.54B | |
| -0.14% | +4.03% | +482.13% | +584.43% | 44.06B | |
| -0.06% | +9.62% | +24.63% | +81.63% | 40.85B | |
| -0.87% | +2.40% | +30.01% | +9.95% | 40.14B | |
| -4.04% | +6.15% | +23.03% | +48.00% | 34.17B | |
| -1.41% | +1.57% | +29.98% | +123.68% | 16.9B | |
| +0.35% | +4.61% | - | - | 16.78B | |
| -0.43% | -0.11% | +4.22% | +20.83% | 14B | |
| +0.84% | +9.07% | +86.17% | +32.60% | 13.46B | |
| Average | -0.77% | +4.21% | +81.34% | +112.32% | 27.02B | |
| Weighted average by Cap. | -1.01% | +5.04% | +103.24% | +136.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.84M 12.52M 10.16M 9.27M 17.42M 1.19B 17.69M 119M 46.71M 598M 46.99M 45.97M 1.99B | 44.83M 51.74M 42M 38.31M 72.03M 4.94B 73.13M 494M 193M 2.47B 194M 190M 8.24B |
| Net income | -31.17M -35.98M -29.21M -26.64M -50.09M -3.43B -50.86M -344M -134M -1.72B -135M -132M -5.73B | 5.02M 5.8M 4.71M 4.29M 8.07M 553M 8.19M 55.36M 21.64M 277M 21.77M 21.3M 923M |
| Net Debt | 38.68M 44.65M 36.24M 33.06M 62.15M 4.26B 63.11M 426M 167M 2.13B 168M 164M 7.11B | 14.72M 16.99M 13.79M 12.58M 23.65M 1.62B 24.01M 162M 63.39M 811M 63.78M 62.39M 2.71B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/08/26 | CHF 11.72 | -0.34% | 55,791 |
| 11/08/26 | CHF 11.76 | -1.18% | 22,599 |
| 10/08/26 | CHF 11.90 | -2.62% | 19,884 |
| 07/08/26 | CHF 12.22 | -0.65% | 24,467 |
| 06/08/26 | CHF 12.30 | +0.33% | 100,553 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NWRN Stock
Select your edition
All financial news and data tailored to specific country editions
